EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access

Evaluating Improvement in Pain and Sensory Function When Using High-Frequency (10-kHz) Spinal Cord Stimulation in Individuals With Painful Diabetic Neuropathy: A Multicenter Randomized Controlled Trial (PDN-Sensory)

Robert W Hurley iD, Elias S Siraj, Shawn Sills, Mitchell Engle, Curtis Johnson, Rodica Pop-Busui, David Armstrong, Andrew Boulton, Brian Levy, Solomon Tesfaye, George Grunberger, Erika Petersen und 14 weitere

Diabetes Care · 2026

DOI: 10.2337/dc26-0758 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Diabetes Care, 2026. Verfasst von Robert W Hurley und 25 weiteren Autor:innen. Beteiligte Einrichtung: Pain Medicine, Anesthesiology, Translational Neuroscience and Public Health, Pain Outcomes Lab, Wake Forest University School of Medicine, Winston-Sa…. Hauptthemen laut MEDLINE: Diabetic Neuropathies, Spinal Cord Stimulation. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Nevro Corp.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE The PDN-Sensory randomized controlled trial (RCT) evaluated the effects of high-frequency 10-kHz spinal cord stimulation (10-kHz SCS) on pain and sensory function in individuals with painful diabetic neuropathy (PDN). RESEARCH DESIGN AND METHODS Participants were randomized 1:1 to conventional medical management (CMM) alone or 10-kHz SCS plus CMM. The primary and key secondary end points were the proportions of participants with pain response (≥50% lower-limb pain relief) and sensory improvement (≥3-point reduction in modified Toronto Clinical Neuropathy Score [mTCNS]). Hierarchical secondary outcomes included intraepidermal nerve fiber density (IENFD), sleep, and health- and neuropathy-related quality of life (QoL). IENFD and mTCNS assessments were allocation blinded. RESULTS A total of 91 participants were randomly assigned to CMM alone (n = 50) or 10-kHz SCS plus CMM (n = 41). In a modified intention-to-treat worst-case analysis, 27 of 34 participants in the 10-kHz SCS group who underwent a temporary trial achieved the primary outcome, versus 2 of 50 CMM-alone participants (P < 0.001). Among those with 6-month data, mTCNS sensory improvement was observed in 16 of 29 (55.2%) 10-kHz SCS participants versus 12 of 48 (25.0%) CMM-alone participants (P = 0.01). The mean change in lower-calf IENFD was 0.58 fibers/mm with 10-kHz SCS versus −0.07 with CMM alone (P = 0.03). Eight of 10 hierarchical secondary end points were met (including sleep and QoL). CONCLUSIONS The PDN-Sensory RCT replicated previous pain-reduction findings and showed prespecified, objective improvements in sensory function and IENFD. These 6-month findings support clinically meaningful benefit and are consistent with a potential disease-modifying effect that requires longer-term confirmation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NeuropathiesSpinal Cord StimulationHumansFemaleMaleMiddle AgedQuality of LifeAgedAdultPain Management

Autor:innen und Institutionen

  • Pain Medicine, Anesthesiology, Translational Neuroscience and Public Health, Pain Outcomes Lab, Wake Forest University School of Medicine, Winston-Salem, NC.
  • Endocrine and Metabolic Disorders, Eastern Virginia Medical School, Norfolk, VA.
  • Pain Management, Touchstone Interventional Pain Center, Medford, OR.
  • Pain Management, Institute of Precision Pain Medicine, Corpus Christi, TX.
  • Pain Management, Midwest Pain Management Center, Lee's Summit, MO.
  • Division of Endocrinology, Diabetes and Clinical Nutrition, Oregon Health & Science University, Portland, OR.

ORCID-Profile: Robert W Hurley

Förderung

  • Nevro Corp

Zitieren

APA

Hurley, R. W., Siraj, E. S., Sills, S., Engle, M., Johnson, C., Pop-Busui, R., Armstrong, D., Boulton, A., Levy, B., Tesfaye, S., Grunberger, G., Petersen, E., Azalde, R., Edgar, D., Nakhle, S., Yu, C., Khan, K., Skaribas, I., Amirdelfan, K., …, & Caraway, D. (2026). Evaluating Improvement in Pain and Sensory Function When Using High-Frequency (10-kHz) Spinal Cord Stimulation in Individuals With Painful Diabetic Neuropathy: A Multicenter Randomized Controlled Trial (PDN-Sensory). Diabetes Care. https://doi.org/10.2337/dc26-0758

Vancouver

Hurley RW, Siraj ES, Sills S, Engle M, Johnson C, Pop-Busui R, et al. Evaluating Improvement in Pain and Sensory Function When Using High-Frequency (10-kHz) Spinal Cord Stimulation in Individuals With Painful Diabetic Neuropathy: A Multicenter Randomized Controlled Trial (PDN-Sensory). Diabetes Care. 2026. doi:10.2337/dc26-0758

BibTeX
@article{Hurley2026,
  author = {Hurley, Robert W and Siraj, Elias S and Sills, Shawn and Engle, Mitchell and Johnson, Curtis and Pop-Busui, Rodica and Armstrong, David and Boulton, Andrew and Levy, Brian and Tesfaye, Solomon and Grunberger, George and Petersen, Erika and Azalde, Rose and Edgar, Deborah and Nakhle, Samer and Yu, Cong and Khan, Khurram and Skaribas, Ioannis and Amirdelfan, Kasra and Nguyen, Quang and Jameson, Jessica and Guirguis, Maged and Bradley, Kerry and Patel, Janus S and Bintrim, Daniel J and Caraway, David},
  title = {Evaluating Improvement in Pain and Sensory Function When Using High-Frequency (10-kHz) Spinal Cord Stimulation in Individuals With Painful Diabetic Neuropathy: A Multicenter Randomized Controlled Trial (PDN-Sensory)},
  journal = {Diabetes Care},
  year = {2026},
  doi = {10.2337/dc26-0758}
}
Kostenlos starten →